These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 15449112

  • 21. Endometrioid adenocarcinoma of the ovary and endometriosis.
    Valenzuela P, Ramos P, Redondo S, Cabrera Y, Alvarez I, Ruiz A.
    Eur J Obstet Gynecol Reprod Biol; 2007 Sep; 134(1):83-6. PubMed ID: 16844279
    [Abstract] [Full Text] [Related]

  • 22. Molecular events associated with arsenic-induced malignant transformation of human prostatic epithelial cells: aberrant genomic DNA methylation and K-ras oncogene activation.
    Benbrahim-Tallaa L, Waterland RA, Styblo M, Achanzar WE, Webber MM, Waalkes MP.
    Toxicol Appl Pharmacol; 2005 Aug 15; 206(3):288-98. PubMed ID: 16039940
    [Abstract] [Full Text] [Related]

  • 23. [Clinical discussion of the relationship between endometriosis and epithelial ovarian cancer].
    Zhang Y, Huang H, Lian L.
    Zhonghua Fu Chan Ke Za Zhi; 1999 Sep 15; 34(9):544-6. PubMed ID: 11360640
    [Abstract] [Full Text] [Related]

  • 24. Cystic and adenofibromatous clear cell carcinomas of the ovary: distinctive tumors that differ in their pathogenesis and behavior: a clinicopathologic analysis of 122 cases.
    Veras E, Mao TL, Ayhan A, Ueda S, Lai H, Hayran M, Shih IeM, Kurman RJ.
    Am J Surg Pathol; 2009 Jun 15; 33(6):844-53. PubMed ID: 19342944
    [Abstract] [Full Text] [Related]

  • 25. Molecular pathogenesis of endometriosis-associated clear cell carcinoma of the ovary (review).
    Kobayashi H, Kajiwara H, Kanayama S, Yamada Y, Furukawa N, Noguchi T, Haruta S, Yoshida S, Sakata M, Sado T, Oi H.
    Oncol Rep; 2009 Aug 15; 22(2):233-40. PubMed ID: 19578761
    [Abstract] [Full Text] [Related]

  • 26. [Epigenetic inactivation of SPOCK2 in the malignant transformation of ovarian endometriosis].
    Ren F, Wang DB, Li T.
    Zhonghua Fu Chan Ke Za Zhi; 2011 Nov 15; 46(11):822-5. PubMed ID: 22333230
    [Abstract] [Full Text] [Related]

  • 27. Integrating modern approaches to pathogenetic concepts of malignant transformation of endometriosis.
    Kobayashi H, Yamada Y, Kawahara N, Ogawa K, Yoshimoto C.
    Oncol Rep; 2019 Mar 15; 41(3):1729-1738. PubMed ID: 30592289
    [Abstract] [Full Text] [Related]

  • 28. CDC42-positive macrophages may prevent malignant transformation of ovarian endometriosis.
    Canet B, Pons C, Espinosa I, Prat J.
    Hum Pathol; 2012 May 15; 43(5):720-5. PubMed ID: 21944080
    [Abstract] [Full Text] [Related]

  • 29. Loss of ARID1A/BAF250a expression in ovarian endometriosis and clear cell carcinoma.
    Xiao W, Awadallah A, Xin W.
    Int J Clin Exp Pathol; 2012 May 15; 5(7):642-50. PubMed ID: 22977660
    [Abstract] [Full Text] [Related]

  • 30. Accumulative copy number increase of MET drives tumor development and histological progression in a subset of ovarian clear-cell adenocarcinomas.
    Yamamoto S, Tsuda H, Miyai K, Takano M, Tamai S, Matsubara O.
    Mod Pathol; 2012 Jan 15; 25(1):122-30. PubMed ID: 21983935
    [Abstract] [Full Text] [Related]

  • 31. Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management.
    Mandai M, Yamaguchi K, Matsumura N, Baba T, Konishi I.
    Int J Clin Oncol; 2009 Oct 15; 14(5):383-91. PubMed ID: 19856044
    [Abstract] [Full Text] [Related]

  • 32. Fibroblast growth factor receptor 2 expression may be involved in transformation of ovarian endometrioma to clear cell carcinoma of the ovary.
    Taniguchi F, Itamochi H, Harada T, Terakawa N.
    Int J Gynecol Cancer; 2013 Jun 15; 23(5):791-6. PubMed ID: 23640291
    [Abstract] [Full Text] [Related]

  • 33. Distinct β-catenin and PIK3CA mutation profiles in endometriosis-associated ovarian endometrioid and clear cell carcinomas.
    Matsumoto T, Yamazaki M, Takahashi H, Kajita S, Suzuki E, Tsuruta T, Saegusa M.
    Am J Clin Pathol; 2015 Sep 15; 144(3):452-63. PubMed ID: 26276776
    [Abstract] [Full Text] [Related]

  • 34. Endometriosis-associated Ovarian Cancers.
    Anglesio MS, Yong PJ.
    Clin Obstet Gynecol; 2017 Dec 15; 60(4):711-727. PubMed ID: 28990985
    [Abstract] [Full Text] [Related]

  • 35. [Clinicopathological features of malignant ovarian neoplasms arising from ovarian endometriosis: a report of 26 cases].
    Qu Y, Wang L, Zhu H.
    Zhonghua Fu Chan Ke Za Zhi; 2001 Aug 15; 36(8):470-2. PubMed ID: 11758181
    [Abstract] [Full Text] [Related]

  • 36. Involvement of the ras genes in female genital tract cancer.
    Mammas IN, Zafiropoulos A, Spandidos DA.
    Int J Oncol; 2005 May 15; 26(5):1241-55. PubMed ID: 15809715
    [Abstract] [Full Text] [Related]

  • 37. Models of endometriosis and their utility in studying progression to ovarian clear cell carcinoma.
    King CM, Barbara C, Prentice A, Brenton JD, Charnock-Jones DS.
    J Pathol; 2016 Jan 15; 238(2):185-96. PubMed ID: 26456077
    [Abstract] [Full Text] [Related]

  • 38. [Pathogenic role of PTEN tumor suppressor gene in ovarian cancer associated to endometriosis].
    Castiblanco G A, Pires N Y, Wistuba O I, Riquelme S E, Andrade M L, Corvalán R A.
    Rev Med Chil; 2006 Mar 15; 134(3):271-8. PubMed ID: 16676097
    [Abstract] [Full Text] [Related]

  • 39. Allelic loss studies do not provide evidence for the "endometriosis-as-tumor" theory.
    Prowse AH, Fakis G, Manek S, Churchman M, Edwards S, Rowan A, Koninckx P, Kennedy S, Tomlinson IP.
    Fertil Steril; 2005 Apr 15; 83 Suppl 1():1134-43. PubMed ID: 15831286
    [Abstract] [Full Text] [Related]

  • 40. Cellular kinetics and K-ras codon 12 mutations according to histomorphometric type of colorectal polyps with epithelial serrated proliferation.
    Hamatani S, Wada R, Morita A, Hasegawa C, Mitsuda A, Hatori T, Nonaka H, Takahashi K, Gomi S, Shibuya K.
    Oncol Rep; 2005 Jul 15; 14(1):121-7. PubMed ID: 15944778
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.